rs146022384
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000828.5(GRIA3):c.1166A>C(p.Lys389Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00057 in 1,122,978 control chromosomes in the GnomAD database, including 2 homozygotes. There are 199 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00087 ( 0 hom., 35 hem., cov: 23)
Exomes 𝑓: 0.00054 ( 2 hom. 164 hem. )
Consequence
GRIA3
NM_000828.5 missense
NM_000828.5 missense
Scores
1
3
10
Clinical Significance
Conservation
PhyloP100: 4.86
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.011986196).
BP6
?
Variant X-123403079-A-C is Benign according to our data. Variant chrX-123403079-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 493545.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Likely_benign=2, Uncertain_significance=1}. Variant chrX-123403079-A-C is described in Lovd as [Likely_benign].
BS1
?
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000871 (98/112551) while in subpopulation NFE AF= 0.00133 (71/53276). AF 95% confidence interval is 0.00108. There are 0 homozygotes in gnomad4. There are 35 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Hemizygotes in GnomAd at 35 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.1166A>C | p.Lys389Thr | missense_variant | 8/16 | ENST00000622768.5 | |
GRIA3 | NM_007325.5 | c.1166A>C | p.Lys389Thr | missense_variant | 8/16 | ENST00000620443.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.1166A>C | p.Lys389Thr | missense_variant | 8/16 | 1 | NM_007325.5 | P4 | |
GRIA3 | ENST00000622768.5 | c.1166A>C | p.Lys389Thr | missense_variant | 8/16 | 5 | NM_000828.5 | A1 | |
GRIA3 | ENST00000620581.4 | c.1166A>C | p.Lys389Thr | missense_variant, NMD_transcript_variant | 8/17 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.000871 AC: 98AN: 112496Hom.: 0 Cov.: 23 AF XY: 0.00101 AC XY: 35AN XY: 34660
GnomAD3 genomes
?
AF:
AC:
98
AN:
112496
Hom.:
Cov.:
23
AF XY:
AC XY:
35
AN XY:
34660
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000791 AC: 145AN: 183214Hom.: 0 AF XY: 0.000768 AC XY: 52AN XY: 67734
GnomAD3 exomes
AF:
AC:
145
AN:
183214
Hom.:
AF XY:
AC XY:
52
AN XY:
67734
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000536 AC: 542AN: 1010427Hom.: 2 Cov.: 20 AF XY: 0.000555 AC XY: 164AN XY: 295625
GnomAD4 exome
AF:
AC:
542
AN:
1010427
Hom.:
Cov.:
20
AF XY:
AC XY:
164
AN XY:
295625
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000871 AC: 98AN: 112551Hom.: 0 Cov.: 23 AF XY: 0.00101 AC XY: 35AN XY: 34725
GnomAD4 genome
?
AF:
AC:
98
AN:
112551
Hom.:
Cov.:
23
AF XY:
AC XY:
35
AN XY:
34725
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
?
AF:
AC:
94
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:5
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 24, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 02, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Uncertain
Dann
Uncertain
DEOGEN2
Benign
T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L;L
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
T
Sift4G
Benign
T;T;T;T
Polyphen
B;.;B;B
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at